Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases

BACKGROUND: Cytokine release syndrome (CRS) is a strong immune system response that can occur as a result of the reaction of a cellular immunotherapy with malignant cells. While the frequency and management of CRS in CAR T-cell therapy has been well documented, there is emerging interest in pre-empt...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Lipei, Pelayo, Alejandra, Shi, Rongye, Ma, Jinxia, Liu, Hui, Cai, Yihua, Prochazkova, Michaela, Somerville, Robert P., Panch, Sandhya R., Shah, Nirali N., Stroncek, David F., Jin, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331024/
https://www.ncbi.nlm.nih.gov/pubmed/35902861
http://dx.doi.org/10.1186/s12967-022-03531-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331024/
https://www.ncbi.nlm.nih.gov/pubmed/35902861
http://dx.doi.org/10.1186/s12967-022-03531-3

Ejemplares similares